Page last updated: 2024-09-04

ym 872 and lomerizine

ym 872 has been researched along with lomerizine in 4 studies

Compound Research Comparison

Studies
(ym 872)
Trials
(ym 872)
Recent Studies (post-2010)
(ym 872)
Studies
(lomerizine)
Trials
(lomerizine)
Recent Studies (post-2010) (lomerizine)
4105100329

Protein Interaction Comparison

ProteinTaxonomyym 872 (IC50)lomerizine (IC50)
Delta-type opioid receptorMus musculus (house mouse)2.43
Voltage-dependent L-type calcium channel subunit beta-1Rattus norvegicus (Norway rat)0.09
Voltage-dependent calcium channel subunit alpha-2/delta-1Rattus norvegicus (Norway rat)0.09
Voltage-dependent N-type calcium channel subunit alpha-1BHomo sapiens (human)2.43
Voltage-dependent N-type calcium channel subunit alpha-1BRattus norvegicus (Norway rat)0.09
Prostaglandin D2 receptor 2Homo sapiens (human)0.09

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartlett, CA; Chiha, W; Fitzgerald, M; Giacci, MK; Harvey, AR; Hodgetts, SI; O'Hare Doig, RL; Smith, NM; Yates, NJ1
Fehily, B; Fitzgerald, M; Gavriel, N; Giacci, MK; Gough, AH; Gray, CGG; Milbourn, HR; Toomey, LM1
Bartlett, CA; Fitzgerald, M; Gopalasingam, G; Majimbi, M; Rodger, J; Toomey, LM1
Bartlett, CA; Fitzgerald, M; Gavriel, N; Gopalasingam, G; Majimbi, M; McGonigle, T; Rodger, J; Toomey, LM1

Reviews

1 review(s) available for ym 872 and lomerizine

ArticleYear
Limiting oxidative stress following neurotrauma with a combination of ion channel inhibitors.
    Discovery medicine, 2017, Volume: 23, Issue:129

    Topics: Animals; Calcium; Central Nervous System; Humans; Imidazoles; Myelin Sheath; Nerve Degeneration; Oxidative Stress; Piperazines; Quinoxalines; Reactive Oxygen Species

2017

Other Studies

3 other study(ies) available for ym 872 and lomerizine

ArticleYear
Specific ion channels contribute to key elements of pathology during secondary degeneration following neurotrauma.
    BMC neuroscience, 2017, 08-14, Volume: 18, Issue:1

    Topics: Animals; Calcium Channel Blockers; Calcium Channels; Disease Models, Animal; Female; Imidazoles; Macrophages; Microglia; Nerve Degeneration; Nystagmus, Optokinetic; Optic Nerve Injuries; Oxidative Stress; Piperazines; Purinergic P2X Receptor Antagonists; Quinoxalines; Random Allocation; Ranvier's Nodes; Rats; Receptors, AMPA; Receptors, Purinergic P2X7

2017
Comparison of ion channel inhibitor combinations for limiting secondary degeneration following partial optic nerve transection.
    Experimental brain research, 2019, Volume: 237, Issue:1

    Topics: Animals; Calcium Channel Blockers; Calcium-Binding Proteins; Cell Adhesion Molecules, Neuronal; Disease Models, Animal; Drug Delivery Systems; Drug Therapy, Combination; Ectodysplasins; Female; Imidazoles; Ion Channels; Macrophages; Microfilament Proteins; Microglia; Nerve Degeneration; Nystagmus, Optokinetic; Oligodendrocyte Transcription Factor 2; Optic Nerve Injuries; Piperazines; Quinoxalines; Rats; Receptor, Platelet-Derived Growth Factor alpha; Rosaniline Dyes; Tubulin

2019
Comparing modes of delivery of a combination of ion channel inhibitors for limiting secondary degeneration following partial optic nerve transection.
    Scientific reports, 2019, 10-25, Volume: 9, Issue:1

    Topics: Animals; Calcium Channel Blockers; Calcium Channels; Drug Therapy, Combination; Female; Imidazoles; Myelin Sheath; Nerve Degeneration; Optic Nerve; Optic Nerve Injuries; Piperazines; Quinoxalines; Rats; Receptors, AMPA; Receptors, Purinergic P2X7; Rosaniline Dyes

2019
chemdatabank.com